Rybelsus 3 mg: Uses, Dosage, Side Effects, and warnings

  Uses:   Rybelsus 3 mg (semaglutide) is a glucagon-like peptide-1 (GLP-1) receptor agonist used in the treatment of type 2 diabetes. It works by imitating the body's natural insulin response after meals to control blood sugar levels. In addition to its primary purpose, some patients may experience weight loss while taking Rybelsus. Dosage:   The starting dosage of Rybelsus is typically 3 mg once daily, taken orally at least 30 minutes before the first meal, beverage, or other oral medication of the day. After 30 days, the dose is usually increased to Rybelsus 7 mg once daily, and then after another 30 days, it may be increased to Rybelsus 14 mg once daily, depending on your body's response and your doctor's guidance. Side Effects:   Common side effects of Rybelsus include: Nausea and Vomiting: These are the most common side effects and can be particularly prominent when you first start taking the medication. These side effects usually subside over time as your body adju